Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Michael Gnant, Brigitte Mlineritsch, Walter Schippinger et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.

S. Boissier, Mercedes Ferreras, Olivier Peyruchaud et al. · PubMed · 2000 · 573 citations

Breast Oncology, Chemoprevention Strategy, Osteoporosis +16

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

Rebecca Aft, Michael Naughton, Kathryn Trinkaus et al. · The Lancet Oncology · 2010 · 270 citations · Full text

Zoledronic Acid, Breast Oncology, Open Label +7

Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer Patients

Daniele Santini, Bruno Vincenzi, Sara Galluzzo et al. · Clinical Cancer Research · 2007 · 169 citations · Full text

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects

Christophe Denoyelle, J. P. Vannier, Jeannette Soria et al. · British Journal of Cancer · 2003 · 155 citations · Full text